FrontPoint's Skowron Charged In Insider-Trading Case

Apr 13 2011 | 11:18am ET

FrontPoint Partners healthcare chief Joseph Skowron was arrested today and charged with insider-trading.

Skowron surrendered to the Federal Bureau of Investigation this morning. According to prosecutors, he used confidential information about Human Genome Sciences supplied by a French doctor, who advised the pharmaceutical, to help his hedge funds at FrontPoint avoid $30 million in losses.

Skowron's alleged tipster, Yves Benhamou, a prominent nephrologist, pleaded guilty on Monday as part of a deal with prosecutors, the U.S. Attorney's office in New York said today. Benhamou, who consulted with at least six hedge funds, was arrested in November.

While authorities only publicly named FrontPoint and Skowron as the hedge fund and hedge fund manager referred to in their complaint against Benhamou, the two were quickly identified in the press, and FrontPoint acknowledged that it was the hedge fund in the case. Investors quickly ran for the door, leading FrontPoint to liquidate its healthcare hedge funds and shutter its healthcare unit, laying off its healthcare team. Skowron himself has been on leave since Benhamou's arrest.

"Dr. Benhamou has acknowledged his serious mistakes in judgment and intends to live up to his obligations under his cooperation agreement," Benhamou's lawyer, David Zornow of Skadden, said. "Dr. Benhamou's conduct in this instance must fairly be considered in the overall context of his extraordinary contributions to his patients and to medical science."

According to prosecutors, Benhamou warned Skowron that a Human Genome hepatitis-C drug trial had produced disappointing results. FrontPoint sold 3.3 million shares of Human Genome in January 2008, before the company announced the results of the drug trial. The move saved the hedge fund some $30 million.

For its part, FrontPoint has continuously said it is "cooperating fully" with the investigation.

Skowron, who holds a Ph.D. in cellular and molecular biology from Yale University, is expected to appear in court later today. He formerly worked at Millennium Partners and SAC Capital Advisors.


In Depth

Hedge Fund Veteran Peter Borish Talks Trading

Dec 17 2014 | 9:32am ET

Peter Borish says 2014 was “tricky” from a trading perspective. “The best...

Lifestyle

Cohen Donates $1.5M To GOP Governors Association

Dec 10 2014 | 7:13am ET

The Republican Governors Association raised close to $25 million from October 1...

Guest Contributor

Q&A With Daniel Gallancy: Institutional Interest In Bitcoin Is Growing Steadily

Dec 12 2014 | 7:54am ET

Daniel Gallancy is founder and CEO of SolidX, a provider of total return swaps for...

 

Sponsored Content

Editor's Note

    Guidelines for Guest Articles

    Oct 22 2014 | 9:46am ET

    We are always looking for guest articles from hedge fund managers and buy-side firms.

    If you are interested in submitting a contributed piece for possible publication on FINalternatives, please take a look at the specs. Read more…

 

Futures Magazine

December 2014 Cover

Futures 2014 person of the year

Jeff Sprecher was simply looking for a platform to trade energies when launching ICE 14 years ago but it has grown to reach the pinnacle of both the listed futures and equities world.

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.